Comparison of plasmakinetic transurethral resection of the prostate with monopolar transurethral resection of the prostate in terms of urethral stricture rates in patients with comorbidities
dc.authorid | BALCI, MUSTAFA BAHADIR CAN/0000-0003-0395-1154; | en_US |
dc.contributor.author | Sinanoğlu, Orhun | |
dc.contributor.author | Ekici, Sinan | |
dc.contributor.author | Balci, M. B. Can | |
dc.contributor.author | Hazar, A. Ismet | |
dc.contributor.author | Nuhoğlu, Baris | |
dc.date.accessioned | 2024-07-12T21:37:21Z | |
dc.date.available | 2024-07-12T21:37:21Z | |
dc.date.issued | 2014 | en_US |
dc.department | [Belirlenecek] | en_US |
dc.description.abstract | Purpose: To compare urethral stricture rates in comorbid patients undergoing plasmakinetic transurethral resection of the prostate (PK-TURP) and monopolar transurethral resection of the prostate (M-TURP) for benign prostatic hyperplasia. Methods: The data of 317 patients with comorbidities undergoing either PK-TURP or M-TURP from September 2008 to December 2012 were retrospectively evaluated. Preoperative and postoperative 12-month International Prostate Symptom Score, maximal flow rate, postoperative International Index of Erectile Function scores, and urethral stricture rates were evaluated. Results: A total of 154 patients underwent M-TURP and 163 patients underwent PK-TURP. Urethral stricture rates were 6/154 in the M-TURP treatment arm and 17/163 in the PK-TURP treatment arm (P= 0.000). In the presence of hypertension and/or coronary artery disease and/or diabetes mellitus, the risk of urethral stricture complication was significantly higher in the PK-TURP group than in the M-TURP group (P= 0.000). Conclusions: The risk of urethral stricture increases with PK-TURP in elderly patients with a large prostate and concomitant hypertension and/or coronary artery disease and/or diabetes mellitus. Therefore, PK-TURP should be performed cautiously in this group of benign prostatic hyperplasia patients. | en_US |
dc.identifier.doi | 10.12954/PI.14043 | |
dc.identifier.endpage | 126 | en_US |
dc.identifier.issn | 2287-8882 | |
dc.identifier.issn | 2287-903X | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 25325023 | en_US |
dc.identifier.startpage | 121 | en_US |
dc.identifier.uri | https://doi.org/10.12954/PI.14043 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12415/6759 | |
dc.identifier.volume | 2 | en_US |
dc.identifier.wos | WOS:000216583200003 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Inc | en_US |
dc.relation.ispartof | Prostate International | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.snmz | KY04101 | |
dc.subject | Prostatic Hyperplasia | en_US |
dc.subject | Comorbidity | en_US |
dc.subject | Transurethral Resection Of Prostate | en_US |
dc.subject | Urethral Stricture | en_US |
dc.title | Comparison of plasmakinetic transurethral resection of the prostate with monopolar transurethral resection of the prostate in terms of urethral stricture rates in patients with comorbidities | en_US |
dc.type | Article | |
dspace.entity.type | Publication |